Clinical trial NCT01434979: Exertional Heat Illness: Biomarkers for Prediction and Return to Duty
Official title: Exertional Heat Illness: Biomarkers for Prediction and Return to Duty
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Heat Illness
Lead sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine
Sponsor class: OTHER
First posted: 2011-09-15
Enrollment: 148
Sex: ALL
Minimum age (years): 18
Maximum age (years): 45
Standard ages: ADULT
Accepts healthy volunteers: yes
Observational model: CASE_CONTROL
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: The target population will include both civilian DOD beneficiary and active duty military men and women, of any race or ethnicity, between the ages of 18 and 45 years.

Brief summary: The investigators goal is to monitor and quantify the differential physiologic and biomarker responses of controls to standardized exercise under thermoneutral and thermally challenged conditions and responses of exertional heat stroke (EHS) subjects under a thermal-challenged environment to develop unique bio-signature panels to predict those at risk for exertional heat illness (EHI) and guide return to duty following an episode of EHS.

Detailed description: Purpose: Our goal is to monitor and quantify the differential physiologic and biomarker responses of controls to standardized exercise under thermoneutral and thermally challenged conditions and responses of exertional heat stroke (EHS) subjects under a thermal-challenged environment to develop unique biosignature panels to predict those at risk for exertional heat illness (EHI) and guide return to duty following an episode of EHS.

Research Design: This is a prospective cross-sectional study.

Methodology/Technical Approach: The proposed study will examine multiple biomarkers in a group of 100 individuals who have not had an episode of EHS and a prospective study of 50 persons who have had an EHS event. Control subjects will have biomarker assessments before and after an exercise challenge under thermoneutral (TTT) and thermally challenged conditions (heat tolerance test/HTT); differences in the responses to the two tests will be attributed to the heat. In EHS subjects, blood will be obtained at time of injury and then followed up at 6 weeks according to non-EHS controls. In addition, EHS cases will be prospectively followed at 3, 6, 12, and 18 months after the 6-week post assessment. If they are heat tolerant at 6-weeks as determined by a HTT, subsequent measures will include only blood samples and questionnaires, whereas if they are heat intolerant (HIT) at 6-weeks, subsequent measures will include additional HTTs, along with blood samples and questionnaires. As our previous data indicate, approximately 20% of non-EHS persons are HIT; we will test 100 non-EHS and 50 EHI persons in this study. Thus, data will be evaluated with regard to thermotolerance. Importantly, all control participants will undergo two test sessions (HTT and TTT); to control for an order effect, we will randomize the tests.

Eligibility criteria: Inclusion Criteria:

* Federal Civilian Employee, Active Duty, or DoD Beneficiary
* Between the ages of 18 and 45 years
* Waist circumference ≤ 39.4 inches (100 cm)
* Willing to walk/run on a treadmill
* Willing to undergo exposure in a thermal chamber
* Willing to maintain their current activity patterns, and to abstain from alcohol, caffeine, and tobacco for 24 hours prior to all sessions
* For cases who have suffered from a exertional heat illness / exertional heat stroke, must have a clinically documented heat stroke within the past year

Exclusion Criteria:

* History of malignant hyperthermia
* Pregnant or lactating
* Have overt heart disease
* Have systolic blood pressure over 140 mm Hg, or diastolic pressure over 90 mm Hg
* Have a waist circumference \> 39.4 inches (100 cm)
* Are older than 45 or younger than 18 years of age
* Are anemic
* Are taking psychotropic medication for any mental health disorder
* Are taking other selected medications (glucose lowering, prednisone or beta blockers)

Primary outcomes:
measure: Heat tolerance
timeFrame: 2-hour heat test
Secondary outcomes:
measure: Fitness
timeFrame: 2-hour heat tolerance test
measure: Behavioral correlates of heat tolerance
timeFrame: past month
measure: Perceived heat strain
timeFrame: 2-hour heat tolerance test and 2-hour control test
Other outcomes:
measure: Blood pressure in response to heat tolerance
timeFrame: 2-hour heat tolerance test and 2-hour control test
Locations:
city: Bethesda
country: United States
facility: Uniformed Services University of the Health Sciences
state: Maryland
city: Tel-Hashomer
country: Israel
facility: Heller Institute of Medical Research
Study officials:
affiliation: Uniformed Services University of the Health Sciences
name: Patricia Deuster, PhD, MPH
role: PRINCIPAL_INVESTIGATOR
References: